Exchanges At Goldman Sachs
Vaccine Progress and What’s Next
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:09:56
- Mas informaciones
Informações:
Sinopsis
Salveen Richter, lead analyst for the US Biotechnology sector in Goldman Sachs Research, talks about Pfizer’s clinical-trial results for its COVID-19 vaccine and the obstacles that still lie ahead for FDA approval and widespread distribution.
